Precision Medicine Group Appoints John Hubbard, PhD, as Board of Directors Chair

BETHESDA, Md., March 13, 2023 /PRNewswire/ — Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointment of John Hubbard, PhD, as Chairman of its Board of Directors. “We are thrilled to welcome…

Leave a Reply

Your email address will not be published. Required fields are marked *